Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans: CSF AD biomarkers measured by Lumipulse in Koreans

BACKGROUND: Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker cutoffs from immunoassays with low interlaboratory variability in diverse ethnic groups are necessary for their use in clinics and clinical trials. With lack of cutoffs from fully automated immunoassay platforms in diverse race...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Sohee, Kim, Sujin, Mankhong, Sakulrat, Choi, Seong Hye, Vandijck, Manu, Kostanjevecki, Vesna, Jeong, Jee Hyang, Yoon, Soo Jin, Park, Kyung Won, Kim, Eun-Joo, Yoon, Bora, Kim, Hee Jin, Jang, Jae-Won, Hong, Jin Yong, Park, Dong-Ho, Shaw, Leslie M., Kang, Ju-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802266/
https://www.ncbi.nlm.nih.gov/pubmed/33436035
http://dx.doi.org/10.1186/s13195-020-00767-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802266/
https://www.ncbi.nlm.nih.gov/pubmed/33436035
http://dx.doi.org/10.1186/s13195-020-00767-3

Ejemplares similares